AusMedtech 2021: Reimagine and reconnect provides a week of virtual half-day sessions that represent Australia’s medtech industry; celebrate the successes and impacts the industry has made, and engage on the reimagined future of medtech.
Kylie Sproston, Bellberry CEO, will be part of a panel discussion being held on Tues 18 May titled ‘Lessons learnt: Clinical trials, ethics and governance, regulatory approvals and the new normal’